HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 192 filers reported holding HORIZON PHARMA PLC in Q2 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $6,712,000 | +43.8% | 253,949 | +6.4% | 0.01% | +30.0% |
Q4 2018 | $4,666,000 | +45.6% | 238,785 | +45.9% | 0.01% | +66.7% |
Q3 2018 | $3,205,000 | +4.4% | 163,686 | -11.7% | 0.01% | 0.0% |
Q2 2018 | $3,069,000 | +19.1% | 185,346 | +2.2% | 0.01% | +20.0% |
Q1 2018 | $2,576,000 | -3.0% | 181,405 | -0.3% | 0.01% | 0.0% |
Q4 2017 | $2,656,000 | -5.6% | 181,896 | -18.0% | 0.01% | -16.7% |
Q3 2017 | $2,813,000 | +12.4% | 221,853 | +5.2% | 0.01% | 0.0% |
Q2 2017 | $2,503,000 | -17.0% | 210,843 | +3.4% | 0.01% | -14.3% |
Q1 2017 | $3,015,000 | -5.0% | 203,972 | +4.0% | 0.01% | -12.5% |
Q4 2016 | $3,175,000 | -6.0% | 196,206 | +5.3% | 0.01% | -11.1% |
Q3 2016 | $3,378,000 | +15.8% | 186,306 | +5.2% | 0.01% | 0.0% |
Q2 2016 | $2,917,000 | +814.4% | 177,140 | +1829.2% | 0.01% | +800.0% |
Q2 2015 | $319,000 | -82.4% | 9,182 | -86.9% | 0.00% | -80.0% |
Q1 2015 | $1,815,000 | +170.1% | 69,891 | +34.2% | 0.01% | +150.0% |
Q4 2014 | $672,000 | +6.7% | 52,096 | +1.5% | 0.00% | 0.0% |
Q3 2014 | $630,000 | – | 51,312 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JABODON PT CO | 187,808 | $4,519,000 | 3.52% |
KNOTT DAVID M | 50,046 | $1,204,000 | 0.51% |
CASTLEARK MANAGEMENT LLC | 362,980 | $8,733,000 | 0.34% |
EAGLE ASSET MANAGEMENT INC | 2,692,100 | $64,771,000 | 0.33% |
USA FINANCIAL FORMULAS | 15,202 | $402,000 | 0.20% |
Qtron Investments LLC | 12,274 | $295,000 | 0.18% |
C WorldWide Group Holding A/S | 491,544 | $11,827,000 | 0.15% |
Gotham Asset Management, LLC | 207,158 | $4,984,000 | 0.08% |
Russell Investments Group, Ltd. | 608,977 | $14,652,000 | 0.03% |
FNY Investment Advisers, LLC | 3,350 | $80,000 | 0.02% |